These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32457399)

  • 1. Determinants of stakeholders' intention to adopt pharmacogenomic.
    Mustapa MAC; Amin L; Mahadi Z
    Pharmacogenomics J; 2020 Dec; 20(6):801-812. PubMed ID: 32457399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of stakeholders' intention to adopt nutrigenomics.
    Mustapa MAC; Amin L; Frewer LJ
    Genes Nutr; 2020 Sep; 15(1):16. PubMed ID: 32962632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining key factors impact on health science students' intentions to adopt genetic and pharmacogenomics testing: a comparative path analysis in two different healthcare settings.
    Koufaki MI; Siamoglou S; Patrinos GP; Vasileiou K
    Hum Genomics; 2022 Mar; 16(1):9. PubMed ID: 35287732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "To do, or not to do?": determinants of stakeholders' acceptance on dengue vaccine using PLS-SEM analysis in Malaysia.
    Arham AF; Amin L; Mustapa MAC; Mahadi Z; Yaacob M; Arham AF; Norizan NS
    BMC Public Health; 2022 Aug; 22(1):1574. PubMed ID: 35982443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of stakeholders' attitudes to xenotransplantation.
    Amin L; Hashim H; Mahadi Z; Che Ngah A; Ismail K
    Xenotransplantation; 2018 Nov; 25(6):e12430. PubMed ID: 29932474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stakeholders' attitudes to outdoor residual spraying technique for dengue control in Malaysia: A PLS-SEM approach.
    Arham AF; Amin L; Mustapa MAC; Mahadi Z; Yaacob M; Ibrahim M
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009493. PubMed ID: 34185785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of the willingness to participate in biobanking among Malaysian stakeholders in the Klang Valley.
    Amin L; Hashim H; Mahadi Z; Ismail K
    BMC Med Res Methodol; 2018 Dec; 18(1):163. PubMed ID: 30518344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of stakeholders' attitudes and intentions toward supporting the use of Wolbachia-infected Aedes mosquitoes for dengue control.
    Arham AF; Amin L; Mustapa MAC; Mahadi Z; Yaacob M; Ibrahim M
    BMC Public Health; 2021 Dec; 21(1):2314. PubMed ID: 34949167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the impact of pre-test education on patient knowledge, perceptions, and expectations of pharmacogenomic testing to guide antidepressant use.
    Sloat NT; Yashar BM; Ellingrod VL; Ward KM
    J Genet Couns; 2022 Dec; 31(6):1373-1382. PubMed ID: 35900228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
    Slomp C; Morris E; Edwards L; Hoens AM; Landry G; Riches L; Ridgway L; Bryan S; Austin J
    Can J Psychiatry; 2023 Jun; 68(6):436-452. PubMed ID: 36437757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative approach to assess the opinion of physicians about the challenges and prospects of pharmacogenomic testing implementation in clinical practice in Greece.
    Koufaki MI; Patrinos GP; Vasileiou KZ
    Hum Genomics; 2024 Jul; 18(1):82. PubMed ID: 39030587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomic-based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system.
    Subasri M; Barrett D; Sibalija J; Bitacola L; Kim RB
    Clin Transl Sci; 2021 Nov; 14(6):2231-2241. PubMed ID: 34080317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare provider and patient perspectives on the implementation of pharmacogenetic-guided treatment in routine clinical practice.
    Kaur G; Nwabufo CK
    Pharmacogenet Genomics; 2024 Sep; 34(7):236-245. PubMed ID: 38917295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacy students' attitudes and intentions of pursuing postgraduate studies and training in pharmacogenomics and personalised medicine.
    Makrygianni D; Koufaki MI; Patrinos GP; Vasileiou KZ
    Hum Genomics; 2023 Mar; 17(1):27. PubMed ID: 36959668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory.
    Haga SB; Liu Y
    Pharmacogenomics; 2019 Jun; 20(8):581-587. PubMed ID: 31190624
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
    Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
    Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.
    Liko I; Lee YM; Stutzman DL; Blackmer AB; Deininger KM; Reynolds AM; Aquilante CL
    Pharmacogenomics; 2021 Apr; 22(5):263-274. PubMed ID: 33657875
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing stakeholders attitudes toward genetically modified aedes mosquito.
    Amin L; Hashim H
    Sci Eng Ethics; 2015 Jun; 21(3):655-81. PubMed ID: 24906652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient perceptions of pharmacogenomic testing in the community pharmacy setting.
    Bright D; Worley M; Porter BL
    Res Social Adm Pharm; 2021 Apr; 17(4):744-749. PubMed ID: 32741696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.